We are live on ! Find out more
TC

Torno Capital Portfolio holdings

AUM $3.47B Turnover 87.5%
1-Year Est. Return 37.88%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+37.88%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$485M
AUM Growth
–
Cap. Flow
+$92.3M
Cap. Flow %
19.06%
Top 10 Hldgs %
46.02%
Holding
222
New
222
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0 years

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.86%
2 Communication Services 5.36%
3 Consumer Staples 1.97%
4 Healthcare 1.22%
5 Consumer Discretionary 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PFIX icon
176
Simplify Interest Rate Hedge ETF
PFIX
$218M
$140K 0.03%
+3,492
New +$314K
2023 Q4
0 quarters
TFII icon
177
TFI International
TFII
$9.41B
$136K 0.03%
+1,000
New +$119K
2023 Q4
0 quarters
IONS icon
178
Ionis Pharmaceuticals
IONS
$7.21B
$126K 0.03%
+2,500
New +$120K
2023 Q4
0 quarters
ENVX icon
179
CALL
Enovix
ENVX
$575M
$125K 0.03%
+11,429
New +$112K
2023 Q4
0 quarters
SIRI icon
180
SiriusXM
SIRI
$9.19B
$109K 0.02%
+2,000
New +$96.1K
2023 Q4
0 quarters
ITCI icon
181
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$107K 0.02%
+1,500
New +$86.3K
2023 Q4
0 quarters
AD icon
182
PUT
Array Digital Infrastructure
AD
$2.92B
$104K 0.02%
+2,500
New +$106K
2023 Q4
0 quarters
ESTA icon
183
CALL
Establishment Labs
ESTA
$1.8B
$104K 0.02%
+4,000
New +$117K
2023 Q4
0 quarters
VIR icon
184
CALL
Vir Biotechnology
VIR
$1.72B
$101K 0.02%
+10,000
New +$91.4K
2023 Q4
0 quarters
APH icon
185
CALL
Amphenol
APH
$200B
$99.1K 0.02%
+4,000
New +$88.4K
2023 Q4
0 quarters
CPRT icon
186
CALL
Copart
CPRT
$25.6B
$98K 0.02%
+2,000
New +$94.5K
2023 Q4
0 quarters
RAAX icon
187
PUT
VanEck Inflation Allocation ETF
RAAX
$1.39B
$84.3K 0.02%
+3,300
New +$84.3K
2023 Q4
0 quarters
CYTK icon
188
Cytokinetics
CYTK
$8.66B
$83.5K 0.02%
+1,000
New +$36.2K
2023 Q4
0 quarters
ACAD icon
189
Acadia Pharmaceuticals
ACAD
$3.34B
$78.3K 0.02%
+2,500
New +$59.7K
2023 Q4
0 quarters
AOUT icon
190
CALL
American Outdoor Brands
AOUT
$226M
$68K 0.01%
+8,100
New +$69.6K
2023 Q4
0 quarters
SAVE icon
191
DELISTED
Spirit Airlines, Inc.
SAVE
$65.6K 0.01%
+4,000
New +$57.6K
2023 Q4
0 quarters
LEGN icon
192
Legend Biotech
LEGN
$3.71B
$60.2K 0.01%
+1,000
New +$63.4K
2023 Q4
0 quarters
SIRI icon
193
CALL
SiriusXM
SIRI
$9.19B
$54.7K 0.01%
+1,000
New +$48K
2023 Q4
0 quarters
COGT icon
194
CALL
Cogent Biosciences
COGT
$5.19B
$54.7K 0.01%
+9,300
New +$71.3K
2023 Q4
0 quarters
VLY icon
195
Valley National Bancorp
VLY
$7.07B
$54.3K 0.01%
+5,000
New +$44.9K
2023 Q4
0 quarters
BGC icon
196
BGC Group
BGC
$5.41B
$54.1K 0.01%
+7,500
New +$46.4K
2023 Q4
0 quarters
RVPH icon
197
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$51.5K 0.01%
+500
New +$44.9K
2023 Q4
0 quarters
PCRX icon
198
Pacira BioSciences
PCRX
$1.45B
$50.6K 0.01%
+1,500
New +$43.9K
2023 Q4
0 quarters
PCTY icon
199
Paylocity
PCTY
$8.77B
$49.5K 0.01%
+300
New +$50.5K
2023 Q4
0 quarters
WOLF icon
200
PUT
Wolfspeed
WOLF
$1.33B
$43.5K 0.01%
+1,000
New +$36.3K
2023 Q4
0 quarters

Similar funds

Torno Capital's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for Torno Capital, which disclosed 222 positions worth $485M. Its ten largest holdings account for 46% of the portfolio.

Its largest position is Sprott Uranium Miners ETF: 547,400 shares worth $26.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, followed by Communication Services and Consumer Staples.

  • Torno Capital's largest Q4 2023 buy was Sprott Uranium Miners ETF: 547,400 shares worth $26.4M.
  • Torno Capital's ten largest holdings make up 46% of its $485M portfolio in Q4 2023.
  • Torno Capital disclosed 222 positions in Q4 2023, its first 13F filing on record.

Based on Torno Capital's 13F filing for Q4 2023, filed 15 Feb 2024.